Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

GenVec GNVC

Healthcare Biotechnology
"Genvec Inc is a biopharmaceutical company. The Company is engaged in leveraging its proprietary AdenoVerse gene delivery platform to develop a pipeline of cutting-edge therapeutics and vaccines."


NDAQ:GNVC - Post by User

GenVec
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Post by allbull1on Mar 03, 2010 5:16am
358 Views
Post# 16836713

great investor support & sentiment.

great investor support & sentiment.the graph's on the ascent amid great investor support & sentiment. If you'd like to know more, the analysis at https://www.itsallbull.net/iabtv.php?string=GNVC_1 is just the thin
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities